FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
4,454 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Entecavir | Entecavir .5 mg/1 | Tablet, Film coatedOral | NorthStar RxLLC | ANDA | 16714-717 | 16714-0717-01 | — |
| Entecavir | Entecavir 1 mg/1 | Tablet, Film coatedOral | NorthStar RxLLC | ANDA | 16714-718 | 16714-0718-01 | — |
| Entecavir | Entecavir anhydrous .5 mg/1 | TabletOral | Camber Pharmaceuticals, Inc. | ANDA | 31722-833 | 31722-0833-3031722-0833-3131722-0833-32+1 more | — |
| Entecavir | Entecavir anhydrous 1 mg/1 | TabletOral | Camber Pharmaceuticals, Inc. | ANDA | 31722-834 |
| 31722-0834-3031722-0834-3131722-0834-32+1 more |
| — |
| Entecavir | Entecavir .5 mg/1 | Tablet, Film coatedOral | AvKARE | ANDA | 42291-261 | 42291-0261-30 | — |
|---|
| Entecavirentecavir anhydrous | Entecavir anhydrous .5 mg/1 | TabletOral | Cameron Pharmaceuticals | ANDA | 42494-457 | 42494-0457-30 | — |
|---|
| Entecavirentecavir anhydrous | Entecavir anhydrous 1 mg/1 | TabletOral | Cameron Pharmaceuticals | ANDA | 42494-458 | 42494-0458-30 | — |
|---|
| Entecavir | Entecavir .5 mg/1 | TabletOral | EPIC PHARMA, LLC | ANDA | 42806-658 | 42806-0658-30 | — |
|---|
| Entecavir | Entecavir 1 mg/1 | TabletOral | EPIC PHARMA, LLC | ANDA | 42806-659 | 42806-0659-30 | — |
|---|
| Entecavir | Entecavir anhydrous .5 mg/1 | Tablet, Film coatedOral | Epic Pharma, LLC | ANDA | 42806-667 | 42806-0667-30 | — |
|---|
| Entecavir | Entecavir anhydrous 1 mg/1 | Tablet, Film coatedOral | Epic Pharma, LLC | ANDA | 42806-668 | 42806-0668-30 | — |
|---|
| Entecavir | Entecavir anhydrous .5 mg/1 | Tablet, Film coatedOral | Solco Healthcare LLC | ANDA | 43547-436 | 43547-0436-0343547-0436-0943547-0436-50 | — |
|---|
| Entecavir | Entecavir anhydrous 1 mg/1 | Tablet, Film coatedOral | Solco Healthcare LLC | ANDA | 43547-437 | 43547-0437-0343547-0437-0943547-0437-50 | — |
|---|
| Entecavir | Entecavir .5 mg/1 | Tablet, Film coatedOral | Yaopharma Co., Ltd. | ANDA | 50771-013 | 50771-0013-0150771-0013-02 | — |
|---|
| Entecavir | Entecavir 1 mg/1 | Tablet, Film coatedOral | Yaopharma Co., Ltd. | ANDA | 50771-014 | 50771-0014-01 | — |
|---|
| Entecavir | Entecavir .5 mg/1 | TabletOral | Golden State Medical Supply, Inc. | ANDA | 51407-589 | 51407-0589-30 | — |
|---|
| Entecavir | Entecavir .5 mg/1 | TabletOral | American Health Packaging | ANDA | 60687-216 | 60687-0216-25 | — |
|---|
| Entecavir | Entecavir .5 mg/1 | TabletOral | Carlsbad Technology, Inc. | ANDA | 61442-311 | 61442-0311-30 | — |
|---|
| Entecavir | Entecavir .5 mg/1 | Tablet, Film coatedOral | Amneal Pharmaceuticals LLC | ANDA | 65162-446 | 65162-0446-03 | — |
|---|
| Entecavir | Entecavir 1 mg/1 | Tablet, Film coatedOral | Amneal Pharmaceuticals LLC | ANDA | 65162-449 | 65162-0449-03 | — |
|---|
| Entecavir | Entecavir .5 mg/1 | TabletOral | Aurobindo Pharma Limited | ANDA | 65862-841 | 65862-0841-3065862-0841-9065862-0841-99 | — |
|---|
| Entecavir | Entecavir 1 mg/1 | TabletOral | Aurobindo Pharma Limited | ANDA | 65862-842 | 65862-0842-3065862-0842-9065862-0842-99 | — |
|---|
| Entecavir | Entecavir .5 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | ANDA | 68382-920 | 68382-0920-0168382-0920-0668382-0920-16+1 more | — |
|---|
| Entecavir | Entecavir 1 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | ANDA | 68382-921 | 68382-0921-0168382-0921-0668382-0921-16+1 more | — |
|---|
| Entecavir | Entecavir 1 mg/1 | Tablet, Film coatedOral | Cipla USA Inc. | ANDA | 69097-425 | 69097-0425-02 | — |
|---|
| Entecavir | Entecavir .5 mg/1 | Tablet, Film coatedOral | Cipla USA Inc. | ANDA | 69097-426 | 69097-0426-0269097-0426-05 | — |
|---|
| Entecavir | Entecavir .5 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | ANDA | 70771-1019 | 70771-1019-0170771-1019-0370771-1019-04+1 more | — |
|---|
| Entecavir | Entecavir 1 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | ANDA | 70771-1020 | 70771-1020-0170771-1020-0370771-1020-04+1 more | — |
|---|
| Enteric Aspirinaspirin | Aspirin 325 mg/1 | Tablet, Delayed releaseOral | Chain Drug Marketing Association, Inc. | OTC monograph drug | 83324-058 | 83324-0058-01 | — |
|---|
| Enteric Coated Aspirinaspirin | Aspirin 325 mg/1 | Tablet, Delayed releaseOral | DISCOUNT DRUG MART | OTC monograph drug | 53943-081 | 53943-0081-02 | — |
|---|
| Enteric Coated Aspirinaspirin | Aspirin 81 mg/1 | TabletOral | Magno-Humphries, Inc. | OTC monograph drug | 54257-274 | 54257-0274-0654257-0274-25 | — |
|---|
| Enteric Coated Aspirinaspirin | Aspirin 325 mg/1 | Tablet, Delayed releaseOral | VALU MERCHANDISERS COMPANY | OTC monograph drug | 63941-181 | 63941-0181-02 | — |
|---|
| Enteric Coated Aspirinaspirin | Aspirin 325 mg/1 | Tablet, Delayed releaseOral | STRATEGIC SOURCING SERVICES LLC | OTC monograph drug | 70677-1122 | 70677-1122-01 | — |
|---|
| Enteric Coated Aspirin Regular Strengthaspirin | Aspirin 325 mg/1 | Tablet, Delayed releaseOral | Safeway | OTC monograph drug | 21130-081 | 21130-0081-05 | — |
|---|
| Enteric Coated Aspirin Regular Strengthaspirin | Aspirin 325 mg/3251 | Tablet, Delayed releaseOral | Time-Cap Labs, Inc | OTC monograph drug | 49483-331 | 49483-0331-0049483-0331-0149483-0331-10 | — |
|---|
| Enteric Coated Aspirin Regular Strengthaspirin | Aspirin 325 mg/1 | Tablet, Delayed releaseOral | Bryant Ranch Prepack | OTC monograph drug | 71335-0157 | 71335-0157-0171335-0157-0271335-0157-03+5 more | — |
|---|
| ENTERO Vu 24%barium sulfate | Barium sulfate 240 mg/mL | SuspensionOral | E-Z-EM Canada Inc | NDA | 32909-146 | 32909-0146-06 | — |
|---|
| Enterovirus Nosode 4444enterovirus nosode | Enterovirus 71 30 [hp_X]/59mL | LiquidOral | Professional Complementary Health Formulas | Unapproved homeopathic | 63083-4444 | 63083-4444-02 | — |
|---|
| Entrestosacubitril and valsartan | Sacubitril 24 mg/1; Valsartan 26 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | NDA | 0078-0659 | 00078-0659-2000078-0659-67 | — |
|---|
| Entrestosacubitril and valsartan | Sacubitril 97 mg/1; Valsartan 103 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | NDA | 0078-0696 | 00078-0696-2000078-0696-67 | — |
|---|
| Entrestosacubitril and valsartan | Sacubitril 49 mg/1; Valsartan 51 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | NDA | 0078-0777 | 00078-0777-2000078-0777-67 | — |
|---|
| Entrestosacubitril and valsartan | Sacubitril 6 mg/1; Valsartan 6 mg/1 | PelletOral | Novartis Pharmaceuticals Corporation | NDA | 0078-1231 | 00078-1231-20 | — |
|---|
| Entrestosacubitril and valsartan | Sacubitril 15 mg/1; Valsartan 16 mg/1 | PelletOral | Novartis Pharmaceuticals Corporation | NDA | 0078-1238 | 00078-1238-20 | — |
|---|
| Entrestosacubitril and valsartan | Sacubitril 24 mg/1; Valsartan 26 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | NDA | 0078-9659 | 00078-9659-50 | — |
|---|
| Entrestosacubitril and valsartan | Sacubitril 49 mg/1; Valsartan 51 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | NDA | 0078-9777 | 00078-9777-50 | — |
|---|
| Entrestosacubitril and valsartan | Sacubitril 49 mg/1; Valsartan 51 mg/1 | Tablet, Film coatedOral | Aphena Pharma Solutions - Tennessee, LLC | NDA | 71610-806 | 71610-0806-32 | — |
|---|
| Entrestosacubitril and valsartan | Sacubitril 97 mg/1; Valsartan 103 mg/1 | Tablet, Film coatedOral | Aphena Pharma Solutions - Tennessee, LLC | NDA | 71610-807 | 71610-0807-37 | — |
|---|
| Entrestosacubitril and valsartan | Sacubitril 24 mg/1; Valsartan 26 mg/1 | Tablet, Film coatedOral | Aphena Pharma Solutions - Tennessee, LLC | NDA | 71610-810 | 71610-0810-3271610-0810-8871610-0810-89 | — |
|---|
| Entyviovedolizumab | Vedolizumab 108 mg/.68mL | Injection, SolutionSubcutaneous | Takeda Pharmaceuticals America, Inc. | BLA | 64764-107 | 64764-0107-11 | — |
|---|
| Entyviovedolizumab | Vedolizumab 300 mg/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | Takeda Pharmaceuticals America, Inc. | BLA | 64764-300 | 64764-0300-20 | J3380 |
|---|